Diabetology & Metabolic Syndrome
Scope & Guideline
Bridging gaps in understanding diabetes and metabolism.
Introduction
Aims and Scopes
- Diabetes Management and Treatment Strategies:
Research on various treatment modalities for diabetes, including pharmacological interventions (like GLP-1 receptor agonists and SGLT2 inhibitors), dietary approaches, and lifestyle modifications aimed at improving glycemic control and managing diabetes-related complications. - Cardiometabolic Health:
Studies investigating the interrelations between diabetes and cardiovascular diseases, metabolic syndrome, and other comorbidities, focusing on risk factors, outcomes, and management strategies. - Pathophysiology of Diabetes Complications:
Research into the underlying mechanisms of diabetes-related complications, including nephropathy, retinopathy, neuropathy, and cardiovascular disease, often utilizing molecular, genetic, and epigenetic analyses. - Innovative Diagnostic and Monitoring Technologies:
Advancements in diabetes monitoring technologies such as continuous glucose monitoring systems, machine learning applications for diabetes risk prediction, and novel biomarkers for early detection of diabetes-related complications. - Public Health and Epidemiology:
Investigations into the prevalence, risk factors, and socio-economic impacts of diabetes and metabolic syndrome at population levels, aiming to inform public health policies and interventions. - Patient-Centered Care and Education:
Research focusing on the psychosocial aspects of diabetes, including patient education, self-management strategies, and the impact of mental health on diabetes outcomes.
Trending and Emerging
- Molecular Mechanisms and Biomarkers:
There is a growing emphasis on understanding the molecular mechanisms underlying diabetes and its complications, including the identification of novel biomarkers for early detection and monitoring of diabetes-related conditions. - Impact of Gut Microbiota:
Research exploring the relationship between gut microbiota and diabetes has gained traction, focusing on how gut health influences metabolic processes, insulin resistance, and overall diabetes management. - Psychosocial and Behavioral Aspects of Diabetes Management:
Increasing attention is being paid to the psychosocial dimensions of diabetes, including the effects of mental health, stress, and social support on diabetes outcomes, as well as the role of patient education and self-management. - Artificial Intelligence and Digital Health Technologies:
The integration of artificial intelligence and digital health technologies in diabetes management is an emerging trend, with studies focusing on predictive modeling, telemedicine, and mobile health applications to enhance patient care. - Diabetes in Special Populations:
Research focusing on diabetes management and outcomes in specific populations, such as children, adolescents, pregnant women, and ethnic minorities, is gaining importance, reflecting the need for tailored approaches in diabetes care.
Declining or Waning
- Traditional Dietary Interventions:
Research focusing solely on traditional dietary interventions for diabetes management, such as specific diets or food groups, has seen a decline. This shift is likely due to a growing emphasis on personalized nutrition and the role of overall dietary patterns. - Single-Agent Pharmacotherapy Studies:
The focus on studies investigating single-agent pharmacotherapy for diabetes management has waned. There is now a greater interest in combination therapies and multi-faceted approaches that address the complexity of diabetes. - Basic Science Studies with Limited Clinical Relevance:
While basic science research remains important, studies that do not translate findings into clinical or practical applications are less prevalent. The journal is increasingly prioritizing research that has direct implications for patient care and outcomes. - Generalized Population Studies:
Research that broadly examines diabetes prevalence without nuanced analysis of specific populations or subgroups is decreasing. There is a trend towards more targeted studies that consider ethnic, cultural, and socio-economic factors influencing diabetes.
Similar Journals
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Empowering Professionals with Cutting-Edge InsightsJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.
Cardiovascular Endocrinology & Metabolism
Bridging Cardiovascular Health and Endocrine InsightsCardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.
DIABETES & METABOLISM
Elevating Knowledge in Endocrinology and Diabetes CareDIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.
Annals of Pediatric Endocrinology & Metabolism
Fostering collaboration for innovative pediatric care solutions.Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.
DIABETES OBESITY & METABOLISM
Delivering cutting-edge research for a healthier future.DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.
BMC Endocrine Disorders
Unlocking insights for a healthier metabolic future.BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.
Diabetologie und Stoffwechsel
Fostering Knowledge for a Healthier TomorrowDiabetologie und Stoffwechsel is a prominent academic journal specializing in the fields of endocrinology, diabetes, and metabolism, published by GEORG THIEME VERLAG KG. Since its inception in 2006, this German journal has strived to disseminate cutting-edge research and innovative findings that advance the understanding of metabolic disorders and the management of diabetes. With an ISSN of 1861-9002 and an E-ISSN of 1861-9010, it caters to a diverse audience ranging from researchers to healthcare professionals and students in the medical field. While it currently holds a Q4 ranking in the 2023 Scopus quartiles for its area, the journal serves as a critical platform for emerging insights and discussions impacting diabetes care and research, fostering collaboration and knowledge-sharing in a rapidly evolving landscape. The convergence of its coverage until 2024 signifies a commitment to ongoing exploration into the complexities of metabolic health, making it a valuable resource for anyone passionate about these vital areas of health.
Turkish Journal of Endocrinology and Metabolism
Connecting Researchers to Transform Endocrinology PracticesThe Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Leading the charge in endocrine research.TRENDS IN ENDOCRINOLOGY AND METABOLISM, published by CELL PRESS, stands as a pivotal resource in the fields of endocrinology, diabetes, and metabolism. With its ISSN 1043-2760 and E-ISSN 1879-3061, this esteemed journal has been a leading platform since its inception in 1989, currently projected to span until 2024. Recognized within the top quartile (Q1) of its category, it boasts impressive Scopus rankings, holding the 4th position in Endocrinology and 8th in Endocrinology, Diabetes, and Metabolism. These rankings underscore its significant impact, evidenced by an impressive percentile rank of 97th and 96th respectively. The journal is committed to facilitating the dissemination of cutting-edge research and innovative insights, making it an essential read for researchers, clinicians, and students seeking to stay informed on the latest advancements in these critical fields. With a robust focus on providing thorough reviews and original research articles, TRENDS IN ENDOCRINOLOGY AND METABOLISM continues to shape the understanding and treatment of metabolic disorders.
DIABETES RESEARCH AND CLINICAL PRACTICE
Advancing diabetes care through impactful research.DIABETES RESEARCH AND CLINICAL PRACTICE, published by Elsevier Ireland Ltd, is a leading peer-reviewed journal in the realms of endocrinology, diabetes, and internal medicine. With a prestigious Q1 classification across several categories, including Endocrinology, Diabetes and Metabolism, and Internal Medicine, this journal is recognized for its impactful contributions to advancing knowledge and clinical practice in diabetes care, boasting an impressive impact factor that underscores its significance in the academic community. Spanning from 1985 to 2024, this journal not only disseminates high-quality research but also serves as a critical resource for healthcare professionals, researchers, and students alike who are focused on addressing the global diabetes epidemic. With its comprehensive scope and commitment to fostering innovative findings, DIABETES RESEARCH AND CLINICAL PRACTICE remains at the forefront of its field, fostering collaboration and discovery to improve patient outcomes.